179 related articles for article (PubMed ID: 34104480)
1. Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study.
Ellithy M; Mitwally H; Saad M; Mathias R; Shaukat A; Elzeer H; Hassan Koya S; Mahmood Z; Gazwi K
Scars Burn Heal; 2021; 7():20595131211015133. PubMed ID: 34104480
[TBL] [Abstract][Full Text] [Related]
2. Patterns of multidrug resistant organism acquisition in an adult specialist burns service: a retrospective review.
Cleland H; Tracy LM; Padiglione A; Stewardson AJ
Antimicrob Resist Infect Control; 2022 Jun; 11(1):82. PubMed ID: 35698209
[TBL] [Abstract][Full Text] [Related]
3. Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome.
Magira EE; Islam S; Niederman MS
Med Intensiva (Engl Ed); 2018 May; 42(4):225-234. PubMed ID: 29033075
[TBL] [Abstract][Full Text] [Related]
4. Value of American Thoracic Society guidelines in predicting infection or colonization with multidrug-resistant organisms in critically ill patients.
Xie J; Ma X; Huang Y; Mo M; Guo F; Yang Y; Qiu H
PLoS One; 2014; 9(3):e89687. PubMed ID: 24647408
[TBL] [Abstract][Full Text] [Related]
5. Multiple-Drug Resistance in Burn Patients: A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay.
van Langeveld I; Gagnon RC; Conrad PF; Gamelli RL; Martin B; Choudhry MA; Mosier MJ
J Burn Care Res; 2017; 38(2):99-105. PubMed ID: 27984411
[TBL] [Abstract][Full Text] [Related]
6. Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.
Martin-Loeches I; Torres A; Rinaudo M; Terraneo S; de Rosa F; Ramirez P; Diaz E; Fernández-Barat L; Li Bassi GL; Ferrer M
J Infect; 2015 Mar; 70(3):213-22. PubMed ID: 25445887
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiological characteristics and outcome analysis of 266 patients with inhalation injuries combined with total burn area less than 30% total body surface area].
Jiang Y; Wang KA; Wang BL; Hu LY; Zhu BH; Wu GS; Sun Y; Xia ZF
Zhonghua Shao Shang Za Zhi; 2021 Apr; 37(4):340-349. PubMed ID: 33887882
[No Abstract] [Full Text] [Related]
8. Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis.
Yin Z; Beiwen W; Zhenzhu M; Erzhen C; Qin Z; Yi D
Sci Rep; 2022 Nov; 12(1):20105. PubMed ID: 36418414
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Empiric Coverage of Previously Cultured Multidrug Resistant Organisms in Critically Ill Patients Admitted for Sepsis.
Padgett CH; King GS; Hughes RE; Hull MN; Colon EA
J Pharm Pract; 2024 Jun; ():8971900241262359. PubMed ID: 38875258
[No Abstract] [Full Text] [Related]
10. [Establishment of an early risk prediction model for bloodstream infection and analysis of its predictive value in patients with extremely severe burns].
Zhang Y; Ma ZZ; Wu BW; Dou Y; Zhang Q; Yang LY; Chen EZ
Zhonghua Shao Shang Za Zhi; 2021 Jun; 37(6):530-537. PubMed ID: 34139830
[No Abstract] [Full Text] [Related]
11. Nosocomial Infections After Pediatric Congenital Heart Disease Surgery: Data from National Center for Cardiovascular Diseases in China.
Wang X; Li S; Huo D; Zhu Z; Wang W; He H; Zhang Q; Li J; Wang X
Infect Drug Resist; 2024; 17():1615-1623. PubMed ID: 38694890
[TBL] [Abstract][Full Text] [Related]
12. Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis.
Prado V; Hernández-Tejero M; Mücke MM; Marco F; Gu W; Amoros A; Toapanta D; Reverter E; Peña-Ramirez C; Altenpeter L; Bassegoda O; Mezzano G; Aziz F; Juanola A; Rodríguez-Tajes S; Chamorro V; López D; Reyes M; Hogardt M; Kempf VAJ; Ferstl PG; Zeuzem S; Martínez JA; Vila J; Arroyo V; Trebicka J; Fernandez J
J Hepatol; 2022 May; 76(5):1079-1089. PubMed ID: 35074475
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Multidrug-Resistant Organism in ICU Burns Patients at Tertiary Care Hospital.
Buriro F; Ishaque S; Saeed A; Qamar MA; Batool A
J Burn Care Res; 2023 Jul; 44(4):949-954. PubMed ID: 36305838
[TBL] [Abstract][Full Text] [Related]
14. Assessment of risk factors associated with multidrug-resistant organism infections among patients admitted in a tertiary hospital - a retrospective study.
Alsehemi AF; Alharbi EA; Alammash BB; Alrais AI; Elbadawy HM; Alahmadi YM
Saudi Pharm J; 2023 Jun; 31(6):1084-1093. PubMed ID: 37293381
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates.
Park S; Kim H; Gatchalian KK; Oh H
Antimicrob Resist Infect Control; 2023 Nov; 12(1):135. PubMed ID: 38012753
[TBL] [Abstract][Full Text] [Related]
16. A Multicenter, Prospective, Observational Study to Determine Predictive Factors for Multidrug-Resistant Pneumonia in Critically Ill Adults: The DEFINE Study.
Lat I; Daley MJ; Shewale A; Pangrazzi MH; Hammond D; Olsen KM;
Pharmacotherapy; 2019 Mar; 39(3):253-260. PubMed ID: 30101412
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients
Mangioni D; Chatenoud L; Colombo J; Palomba E; Guerrero FA; Bolis M; Bottino N; Breda G; Chiaruttini MV; Fior G; Marotta M; Massobrio G; Matinato C; Muscatello A; Previtali P; Santambrogio S; Tardini F; Zuglian G; Grasselli G; Fumagalli R; Gori A; Stocchetti N; Monti G; Bandera A;
Emerg Infect Dis; 2023 Aug; 29(8):1598-1607. PubMed ID: 37486196
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after Surgery among Patients Diagnosed with One or More Multi-Drug-Resistant Organisms.
Gupta A; Tennakoon L; Spain DA; Forrester JD
Surg Infect (Larchmt); 2021 Sep; 22(7):722-729. PubMed ID: 33471591
[No Abstract] [Full Text] [Related]
19. Risk factors for multidrug-resistant Gram-negative infection in burn patients.
Vickers ML; Dulhunty JM; Ballard E; Chapman P; Muller M; Roberts JA; Cotta MO
ANZ J Surg; 2018 May; 88(5):480-485. PubMed ID: 28853230
[TBL] [Abstract][Full Text] [Related]
20. A Multicenter Retrospective Study on Clinical Characteristics and Outcome of Pyogenic Liver Abscess Focusing Multidrug-Resistant Organisms.
Park JW; Kim JH; Jung JH; Kim SE; Kim HS; Jeong H; Suk KT; Jang MK; Kim DJ; Lee MS; Park SH
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
